Hyundai Pharm recently ranked among the top searched stocks on 2 days within the past month.


As of 2:31 PM on the 12th, Hyundai Pharm is trading at 6,410 KRW, down 3.17% from the previous day. This represents a 16.55% increase compared to September 24. Hyundai Pharm is known as a manufacturer of health beverages and pharmaceuticals, including Miero Fiber.

Over the past 5 days, individual investors have net purchased 241,267 shares, while foreigners and institutions have net sold 105,823 shares and net purchased 7,744 shares, respectively.


On October 8, Hyundai Pharm became a market issue with the news of the effectiveness of the "red medicine" Povidone Iodine, causing a sharp rise.



※Source: AI Investment Assistant AI Rasero


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing